Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker MedSurg & Neurotechnology by Quarter
MedSurg & Neurotechnology — Organic Net Sales Growth YoY (%) (%)
Stryker MedSurg & Neurotechnology: 9.1% in Q3 2026, up 0.7 pts from a year earlier.
Latest, Q3 2026
9.1%
Period ended Sep 30, 2026
Change on a year earlier
+0.7 pts
8.4% in Q3 2025
History
19 quarters
Since Q1 2022
Sources
19
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K & Form 10-K/10-Q MD&A.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up medSurg & Neurotechnology
- MedSurg & Neurotechnology — Unit Volume & Product Mix Growth YoY (%)8.9% · Q3 2026
- MedSurg & Neurotechnology — Selling Price Growth Impact YoY (%)0.2% · Q3 2026
- MedSurg & Neurotechnology — Constant Currency Growth YoY (%)9.2% · Q3 2026
- MedSurg & Neurotechnology — Acquisitions / Divestitures Impact YoY (%)0.1% · Q3 2026
- MedSurg & Neurotechnology — Foreign Currency Impact YoY (%)0.0% · Q3 2026
- MedSurg & Neurotechnology — Reported Growth YoY (%)9.2% · Q3 2026
Cite this data
StockData. (2026). Stryker MedSurg & Neurotechnology (%), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-medsurg-org
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.